{"blog": [], "keywords": [{"value": "Pearson, John Michael (1959- )", "name": "persons", "rank": "1", "is_major": "Y"}, {"value": "Valeant Pharmaceuticals International Inc", "name": "organizations", "rank": "2", "is_major": "Y"}, {"value": "Appointments and Executive Changes", "name": "subject", "rank": "3", "is_major": "N"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "4", "is_major": "N"}, {"value": "Schiller, Howard B", "name": "persons", "rank": "5", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/01/14/business/ailing-valeant-chiefs-return-date-is-uncertain.html", "document_type": "article", "byline": {"person": [{"lastname": "POLLACK", "firstname": "Andrew", "role": "reported", "organization": "", "rank": 1}], "original": "By ANDREW POLLACK"}, "type_of_material": "News", "multimedia": [{"url": "images/2016/01/14/business/14valeant-web/14valeant-web-thumbWide.jpg", "legacy": {"wide": "images/2016/01/14/business/14valeant-web/14valeant-web-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2016/01/14/business/14valeant-web/14valeant-web-articleLarge.jpg", "legacy": {"xlarge": "images/2016/01/14/business/14valeant-web/14valeant-web-articleLarge.jpg", "xlargeheight": "431", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 431}, {"url": "images/2016/01/14/business/14valeant-web/14valeant-web-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/01/14/business/14valeant-web/14valeant-web-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "Business Day", "word_count": "475", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "The drug maker\u2019s acting C.E.O., Howard B. Schiller, said it was uncertain when J. Michael Pearson, who Valeant said had been hospitalized with severe pneumonia, would be back.", "pub_date": "2016-01-14T00:00:00Z", "news_desk": "Business", "headline": {"print_headline": "Valeant Official Says Chief&#8217;s Return Date Is Uncertain ", "main": "Ailing Valeant Chief&#8217;s Return Date Is Uncertain "}, "print_page": "4", "snippet": "The drug maker\u2019s acting C.E.O., Howard B. Schiller, said it was uncertain when J. Michael Pearson, who Valeant said had been hospitalized with severe pneumonia, would be back.", "_id": "5696f7a038f0d865e6c34986", "slideshow_credits": null, "abstract": "Valeant Pharmaceuticals interim chief executive Howard B Schiller says it is unclear when J Michael Pearson will return as chief; Pearson is recovering from pneumonia."}